MedTrace Logo

Cardiac Magnetic Resonance in Children With Muscular Dystrophy

NCT01081080 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2013-01-11

No results posted yet for this study

Summary

This protocol will exploit novel state of the art cardiovascular magnetic resonance techniques to examine important changes in the heart in children with muscular dystrophy. The purpose of this study is to compare cardiac magnetic resonance (CMR) with the collected cardiac outcome data obtained in protocol: PITT1109 - Cardiac Outcome Measures in Children with Muscular Dystrophy.

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Cooperative International Neuromuscular Research Group

    lead NETWORK

Principal Investigators

  • Paula R Clemens, MD · University of Pittsburgh

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2011-10-31
Completion
2011-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01081080 on ClinicalTrials.gov